↓ Skip to main content

Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study

Overview of attention for article published in BMC Cancer, January 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study
Published in
BMC Cancer, January 2021
DOI 10.1186/s12885-021-07790-z
Authors

Beachler, Daniel C., de Luise, Cynthia, Jamal-Allial, Aziza, Yin, Ruihua, Taylor, Devon H., Suzuki, Ayako, Lewis, James H., Freston, James W., Lanes, Stephan

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 50%
Student > Bachelor 1 25%
Researcher 1 25%
Readers by discipline Count As %
Medicine and Dentistry 3 75%
Pharmacology, Toxicology and Pharmaceutical Science 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2021.
All research outputs
#11,374,437
of 17,549,474 outputs
Outputs from BMC Cancer
#3,068
of 6,394 outputs
Outputs of similar age
#199,036
of 330,226 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 17,549,474 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,394 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,226 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them